A Study to Evaluate the Pharmacokinetics,Safety and Tolerability of Y-2 Sublingual Tablet in Healthy Adult Subjects

NCT05940883 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Y-2 Sublingual Tablet
DRUG: Y-2 Sublingual Tablet
DRUG: Y-2 Sublingual Tablet
DRUG: Y-2 Sublingual Tablet
DRUG: Y-2 Sublingual Tablet
DRUG: Placebo

Sponsor

Simcere Pharmaceutical Co., Ltd